This is the very goal that Korea Vaccine Co., Ltd. we have pursued throughout the past five decades.

As an experienced manufacturer specializing in the production of preventive medicines and medical devices, we have tried to contribute to public health for over the pas half a century since established in 1956, and have much striven for researching, producing and delivering products par excellence since Ha Chang-hwa assumed office as Charirman iin 1976.

As of now, whe operate the Pharmaceutical Product Division(PPD) and the Medical Device Division(MDD) derived from the initial division;the former specially develops and produces prophylactic vaccines, and the latter a variety of medical devices such as syringe.

Based on the fruit of efforts accumulated for those days, the PPD is developing and holding several unique techniques for microorganism cultivation and purification, for example, 'A technique for making polio vaccine stabilized' and accelerating the development of new products in cooperation with worldwide foremost entities including japan BCG Laboratory (Japan), RIMD of Osaka Uniersity (Japan), GlaxoSmithKline(UK), Aventis Pasteur(France), Chiron(Italy), Statens Serum Institut(Denmark) and Shanghai Institute tof BIological Product (China), In addition, the Division has set up a prompt distribution system giving first priority to the safety of products on the basis of its nationwide branch network, having spread a direct-marketing structure for hospitals/clinics.